Unleash the Future of Drug Discovery with Molecule GEN: Your AI Odyssey Begins Here!

In the fast-paced realm of drug discovery, Molecule GEN stands as a beacon of innovation, promising a quantum leap in the way we approach pharmaceutical br...

December 03, 2023 | Sunday | News
ReWalk Robotics Showcases AI in Exoskeleton Prototype

ReWalk Robotics, Ltd. (Nasdaq: RWLK) ("ReWalk" or the "Company"), a leading provider of innovative technologies that enable mobility and wellness in r...

November 28, 2023 | Tuesday | News
iCAD and GE Healthcare Collaborate to Boost Breast Cancer Detection with AI Solutions

Key apps from the iCAD Breast Health Suite are now integrated with GE HealthCare’s new MyBreastAI Suite* AI applications streamline workflow and s...

November 28, 2023 | Tuesday | News
Genentech, NVIDIA Partner for Strategic AI Collaboration in Drug Discovery

- Collaboration leverages expertise in artificial intelligence from Genentech and NVIDIA to unlock scientific innovation and empower R&D at a sca...

November 22, 2023 | Wednesday | News
Wipro and NVIDIA Collaborate to Integrate Generative AI into Healthcare Insurance

Wipro Limited  a leading technology services and consulting company, today announced a collaboration with NVIDIA to help healthcare companies accelera...

November 22, 2023 | Wednesday | News
AstraZeneca's Global Initiative Surpasses 1 Million Lives Touched in the Fight Against Lung Cancer

Major Milestone Met in AI-Powered Fight Against Lung Cancer Global initiative gains significant ground in digitally identifying cancer risk before s...

November 22, 2023 | Wednesday | News
Exactech AI Platform Surpasses 100,000 Joint Replacement Surgeries Worldwide

“We are proud to reach this incredible milestone of more than 100,000 patients with the support of our surgeon partners worldwide,” said Exacte...

November 21, 2023 | Tuesday | News
DiagnaMed Expedites CERVAI™ Brain Health AI Platform Commercialization Through SOPHIE Program Acceptance.

The SOPHIE program supports collaborative projects for Ontario-based life science firms in the later stages of commercialization. DiagnaMed can leverage fu...

November 16, 2023 | Thursday | News
Charles River and Aitia Partner to Advance Logica in Neurodegenerative and Oncology Discoveries

Strategic partnership includes co-development of patient-derived xenograft (PDX) Digital Twins for in vivo oncology research Charles River to make an eq...

November 14, 2023 | Tuesday | News
Intelligent Scopes, a Claritas HealthTech Subsidiary, Takes Charge of Global Deployment for CystoSmart™ AI Diagnostic Software in Bladder Cancer Detection

Claritas, a leader in image enhancement and AI diagnostic solutions has developed pioneering technology for real-time precision detection of conditions in ...

November 13, 2023 | Monday | News
BioPhy Launches Breakthrough AI Platform to Accelerate the Trillion Dollar Drug Development Market

BioPhy  launched its AI operating system that radically accelerates the identification and development of the most promising drug candidates. By combi...

November 08, 2023 | Wednesday | News
Data and AI in Life Sciences: Shaping the Future - An Exclusive Interview with Mr. Shakti Nagappan, CEO of Telangana Life Sciences

In a rapidly evolving world where data and artificial intelligence have become paramount, BioAsia 2024 presents a theme that transcends traditional boundar...

October 27, 2023 | Friday | Interaction
Accenture Acquires ConcentricLife to Strengthen Healthcare Marketing in Life Sciences

Founded in 2002, ConcentricLife is recognized as one of the MM+M Agency 100, the industry's definitive guide to the top agencies in the health landscape. I...

October 26, 2023 | Thursday | News
Gero Secures $6M to Unlock Aging's Secrets with Physics-Powered GenAI Biotech"

Gero, a biotechnology company focused on aging and chronic diseases, has closed $6M in a Series A extension round. This funding round positions Gero to con...

October 19, 2023 | Thursday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2023 Biopharma Boardroom. All Rights Reserved.


Forgot your password?



Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in